Irish Journal of Medical Science

, Volume 158, Issue 6, pp 137–140 | Cite as

c-erbB-2 oncoprotein expression in malignant and nonmalignant breast tissue

  • A. McCann
  • P. A. Johnston
  • P. A. Dervan
  • W. J. Gullick
  • D. N. Carney


Using a specific polyclonal antibody (21) to the c-erbB-2 oncoprotein, a total of 200 primary breast carcinomas of various histological types and 46 benign breast lesions, were immunohistochemically stained, to identify those tissues over-expressing this putative transmembrane receptor. Positivity for this oncoprotein was evident as an intense brown granular staining predominantly located at the cell membrane and was present in 17% (n=34) of the primary breast carcinomas investigated. With the exception of one case of apocrine metaplasia, none of the remaining benign breast samples (n=45) were positive for this oncoprotein. This study shows that overexpression of the c-erb B-2 oncoprotein is easily identifiable and can be detected on paraffin embedded sections using an immunohistochemical technique. The results obtained correlate well with other c-erbB2 detection systems and in addition, positivity for this oncoprotein is mostly confined to the malignant phenotype.


Epidermal Growth Factor Receptor Human Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor Gene Primary Breast Carcinoma Benign Breast Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Escot, C., Theillet, C., Lidereau, R., et al. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc. Natl. Acad. Sci. USA 1986:83, 4834–4838.PubMedCrossRefGoogle Scholar
  2. 2.
    Mariani-Costantini, R., Escot, C., Thelliet, C., et al. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res. 1988:48, 199–205.PubMedGoogle Scholar
  3. 3.
    Ro, J., North, S.M., Gallick, G.E., Hortobagyi, G.N., Gutterman, Ju. and Blick, M. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinomas. Cancer Res. 1988:48, 161–164.PubMedGoogle Scholar
  4. 4.
    Slamon, D.J., Clark, G.M., Woing, S.G., Levin, W.J. Ullrich, A. and McGuire, W.L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987:235, 177–182.PubMedCrossRefGoogle Scholar
  5. 5.
    Berger, M.S., Locher, G.W., Saurer, S., et al Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 1988:48, 1238–1243.PubMedGoogle Scholar
  6. 6.
    Zhou, D., Battifora, H., Yokota, J., Yamamoto, T. and Cline, M.J. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res. 1987:47, 6123–6125.PubMedGoogle Scholar
  7. 7.
    King, C.R., Kraus, M.H. and Aaronson, S.A. Amplification of a novel v-erb Brelated gene in a human mammary carcinoma. Science 1985: 229, 974–976.PubMedCrossRefGoogle Scholar
  8. 8.
    Kraus, M.H., Popescu, N.C., Amsbaugh, S.C. and King, C.R. Overexpression of the EGF receptor-related protooncogene erb-B2 in human mammary tumour cell lines by different molecular mechanisms. EMBOJ, 1987:6, 605–610.Google Scholar
  9. 9.
    Schechter, A.L., Hung.M.C. Vaidyanathan, L. et al. A neu gene: and erb B-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Nature (Lond) 1985:229, 976–978.Google Scholar
  10. 10.
    Schechter, A.L., Stem, D.F., Vaidyanathan, L. et al. A neu oncogne: An erb B-related gene encoding a 185,000 - M tumour antigen. nature (Lond) 1984:312, 513–516.CrossRefGoogle Scholar
  11. 11.
    Bargmann, C.I. Hung, M.C. and Weinberg, R.A. Multiple independent activiations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 1986: 45, 649–657.PubMedCrossRefGoogle Scholar
  12. 12.
    Coussens, L., I. Yang-Feng, Y.L. Liao, Y.C. et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncognee. Science (Wash DC) 1985:230, 1132–1185.CrossRefGoogle Scholar
  13. 13.
    Fukushige, S., Matsubaru, K., Yoshida, M. et al. Localization of a novel v-erb B-related Gene, c-erbB-2 on human chromosome-17 and its amplification in a gastric cell line. Mol. Cell. Biol. 1986:6, 955–958.PubMedGoogle Scholar
  14. 14.
    Yamamoto, T., Ikawa, S., Akiyama, T. et al. Similarity of protein encoded by human c-erbB-2 gene to epidermal growth factor receptor. Nature (Lond.) 1986:319, 230–235.CrossRefGoogle Scholar
  15. 15.
    Bargmann, C.I., Hung, M.C. and Weiberg, R.A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (Lond.) 1986: 319, 226–230.CrossRefGoogle Scholar
  16. 16.
    Yokota, J., Terada, M., Toyoshima, K. et al. Amplification of the C-erb B2 oncogene in human adenocarcinomas in vivo. Lancet 1986: 1, 765–767.PubMedCrossRefGoogle Scholar
  17. 17.
    Tal., M., Wetzler, M., Josefberg, A. et al. Sporadic amplification of the HER 2/neu protooncogene in adenocarcinomas of various Tissues. Cancer Res. 1988: 48, 1517–1520.PubMedGoogle Scholar
  18. 18.
    Semba, K., Kamata, N., Toyoshima, K. and Yamamoto, T.A. v-erb B-related protooncogene, C-erb B2, is distinct from the C-erb B1/Epidermal growth factor gene and is amplified in a human salivary gland tumour. Proc. Natl. Acad. Sci. (USA. DC) 1985: 82, 6497–6501.CrossRefGoogle Scholar
  19. 19.
    Gullick, W.J. Berger, M.S., Bennett, P.L.P., Rothbard, J.B. and Waterfield M.D. Expression of the c-erbB-2 protein in normal and transformed cells. Int. J. Cancer 1987: 40, 246–254.PubMedCrossRefGoogle Scholar
  20. 20.
    Venter, D.J. Tuzi, N.L. Kumar, S. and Gullick, W.J. Overexpression of the c-erb B-2 oncoprotein in human breast carcinomas immunohistological assessment correlates with gene amplification. Lancet 1987: 2, 69–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Gusterson, B.A., Gullick, W.J., Benter, D.J. et al. Immunohistochemocal localisation of c-erbB-2 in human breast carcinomas, Mol. Cell Probes 1987: 1, 383–391.PubMedCrossRefGoogle Scholar
  22. 22.
    Hsu, S.M., Raine, L. and Fanger, H. The Use of Avidin-biotin-peroxidase Complex (ABC) in Immunioperoxidase Technique: A comparison between ABC and unlabelled antibody (PAP) procedures J. Histochem. Cytochem. 1981: 29, 577–580.PubMedGoogle Scholar
  23. 23.
    Di Fiori, P.P. Pierce, J.H., Kraus, M.H., Segato, O., King, C.R. and Aaronson S.A. erb B2 is a potent oncogene when overexpressed in NIH 3T3 Cells. Science 1987: 237, 178- 182.CrossRefGoogle Scholar
  24. 24.
    Hudziak, R.M., Schlessinger, J. and Ullrich, A. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tunourigenesis of NIH 3T3 Cells. Proc. Natl. Acad. Sci. USA 1987: 6, 3341–3351.Google Scholar
  25. 25.
    Akiyama, T., Sudo, C., OPgawara, H., Toyoshima, K. and Yamamoto, T. The product of the human c-erbB-2 gene. A 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986: 232, 1644–1646.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 1989

Authors and Affiliations

  • A. McCann
    • 1
  • P. A. Johnston
    • 1
  • P. A. Dervan
    • 1
  • W. J. Gullick
    • 2
  • D. N. Carney
    • 3
  1. 1.The Departments of Medical Oncology and Pathology, Mater Misericordiae HospitalUniversity College DublinDublin 7
  2. 2.Imperial Cancer Research FundClinical Oncology Group, Hammersmith HospitalLondonEngland
  3. 3.Department of Medical OncologyMater Misericordiae HospitalDublin 7

Personalised recommendations